| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BIIB | BIOGEN INC. | Rowinsky Eric K | Director | Feb 15, 2024 | Buy | $222.54 | 455 | 101,256 | 20,629 | Feb 20, 2024, 09:13 PM | |
| VSTM | Verastem, Inc. | Rowinsky Eric K | Director | Sep 05, 2017 | Buy | $3.84 | 2,000 | 7,680 | 2,000 | Jan 24, 2024, 04:00 PM | |
| FBIO | Fortress Biotech, Inc. | Rowinsky Eric K | Director | Feb 10, 2023 | Buy | $0.83 | 11,976 | 10,000 | 931,976 | Feb 14, 2023, 04:11 PM | |
| FBIO | Fortress Biotech, Inc. | Rowinsky Eric K | Director | Feb 19, 2021 | Sale | $4.31 | 8,000 | 34,480 | 730,000 | Apr 09, 2021, 05:25 PM | |
| FBIO | Fortress Biotech, Inc. | Rowinsky Eric K | Director | Mar 02, 2021 | Sale | $4.45 | 10,000 | 44,500 | 720,000 | Apr 09, 2021, 05:25 PM | |
| FBIO | Fortress Biotech, Inc. | Rowinsky Eric K | Director | Feb 05, 2021 | Sale | $3.80 | 4,000 | 15,200 | 746,000 | Apr 09, 2021, 05:25 PM | |
| FBIO | Fortress Biotech, Inc. | Rowinsky Eric K | Director | Feb 16, 2021 | Sale | $3.86 | 2,000 | 7,720 | 744,000 | Apr 09, 2021, 05:25 PM | |
| FBIO | Fortress Biotech, Inc. | Rowinsky Eric K | Director | Feb 18, 2021 | Sale | $4.20 | 6,000 | 25,200 | 738,000 | Apr 09, 2021, 05:25 PM | |
| NAVB | NAVIDEA BIOPHARMACEUTICALS, INC. | Rowinsky Eric K | Director | Feb 20, 2018 | Option Exercise | $0.00100 | 50,000 | 50 | 341,446 | Feb 22, 2018, 05:40 PM | |
| NAVB | NAVIDEA BIOPHARMACEUTICALS, INC. | Rowinsky Eric K | Director | Jun 30, 2017 | Option Exercise | $0.00100 | 50,000 | 50 | 291,446 | Jun 30, 2017, 04:35 PM | |
| BIND | DNIB UNWIND, INC. | Rowinsky Eric K | Director | Aug 29, 2016 | Option Exercise | $0.44 | 15,000 | 6,600 | 15,000 | Aug 30, 2016, 04:44 PM | |
| NAVB | NAVIDEA BIOPHARMACEUTICALS, INC. | Rowinsky Eric K | Director | Apr 08, 2016 | Option Exercise | $1.14 | 10,726 | 12,228 | 196,446 | Apr 29, 2016, 04:27 PM | |
| STML | STEMLINE THERAPEUTICS INC | Rowinsky Eric K | Chief Medical Officer | Apr 27, 2015 | Sale | $15.77 | 10,824 | 170,694 | 143,688 | Apr 28, 2015, 06:30 PM | |
| BIIB | BIOGEN INC. | Rowinsky Eric K | Director | Mar 20, 2015 | Sale | $267.41 | 23,334 | 6,239,745 | 22,977 | Mar 23, 2015, 04:33 PM | |
| BIIB | BIOGEN IDEC INC. | Rowinsky Eric K | Director | Mar 19, 2015 | Option Exercise | $247.98 | 4,666 | 1,157,068 | 13,643 | Mar 20, 2015, 05:03 PM | |
| BIIB | BIOGEN IDEC INC. | Rowinsky Eric K | Director | Mar 17, 2015 | Sale | $242.64 | 9,334 | 2,264,769 | 15,977 | Mar 18, 2015, 05:03 PM | |
| BIIB | BIOGEN IDEC INC. | Rowinsky Eric K | Director | Mar 09, 2015 | Sale | $238.53 | 9,332 | 2,225,915 | 15,976 | Mar 11, 2015, 04:15 PM | |
| STML | STEMLINE THERAPEUTICS INC | Rowinsky Eric K | Chief Medical Officer | Feb 18, 2015 | Sale | $13.99 | 1,640 | 22,944 | 130,133 | Feb 20, 2015, 05:42 PM | |
| NAVB | NAVIDEA BIOPHARMACEUTICALS, INC. | Rowinsky Eric K | Director | Nov 10, 2014 | Option Exercise | $1.32 | 9,470 | 12,500 | 163,720 | Nov 12, 2014, 11:08 AM | |
| STML | STEMLINE THERAPEUTICS INC | Rowinsky Eric K | Chief Medical Officer | Apr 25, 2014 | Sale | $15.03 | 11,179 | 168,004 | 132,073 | Apr 28, 2014, 06:38 PM | |
| BIIB | BIOGEN IDEC INC. | Rowinsky Eric K | Director | Jan 21, 2014 | Sale | $310.09 | 2,020 | 626,382 | 10,440 | Jan 22, 2014, 04:49 PM | |
| STML | STEMLINE THERAPEUTICS INC | Rowinsky Eric K | Chief Medical Officer | Nov 25, 2013 | Sale | $20.56 | 13,903 | 285,846 | 128,966 | Nov 27, 2013, 08:24 PM | |
| STML | STEMLINE THERAPEUTICS INC | Rowinsky Eric K | Chief Medical Officer | Aug 01, 2013 | Option Exercise | $27.88 | 6,745 | 188,051 | 143,869 | Aug 05, 2013, 08:02 PM | |
| BIIB | BIOGEN IDEC INC. | Rowinsky Eric K | Director | Jan 06, 2012 | Sale | $87.91 | 25,984 | 2,284,253 | 20,802 | Jan 09, 2012, 03:52 PM | |
| NEOP | NEOPROBE CORP | Rowinsky Eric K | Director | Aug 19, 2011 | Buy | $2.55 | 15,000 | 38,250 | 15,000 | Aug 23, 2011, 08:08 AM |
Menu